Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer

British Journal of Cancer

Volumn 66, Issue 5, 1992, Pages 970-976

  Gasparini, G ^a   Bevilacqua, P ^a   Pozza, F ^a   Meli, S ^a   Boracchi, P ^b   Marubini, E ^b   Sainsbury, J R C ^c  

^a St Bortolo Regional Medical Center   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c HUDDERSFIELD ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CELL GROWTH; CELL KINETICS; COMPARATIVE STUDY; EARLY CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL DIVISION; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGE; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; NEOPLASM STAGING; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T;

EID: 0026461059     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1992.394     Document Type: Article

References (50)

1. BENNETT, S. (1983). Log-logistic regression models for survival data. Appl. Statist., 32, 165-171.
2. BEVILACQUA, P., GASPARINI, G., DAL FIOR, S. & CORRADI, G. (1990). Immunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients. Oncology, 47, 313-317.
3. BLAMEY, R. (1989). Does biological understanding influence surgical practice? Br. J. Cancer, 60, 271-274.
4. BLOOM, H. J. G. & RICHARDSON, W. W. (1957). Histological grading and prognosis. Br. J. Cancer, 11, 359-377.
5. BONADONNA, G. (1990). Adjuvant chemotherapy in node negative breast cancer. NCI Consensus Conference. Eur. J. Cancer, 26, 844-845.
6. CHAN, P. K., FRAKES, R., TAN, E. M., BRATTAIN, M. G., SMETANA, K. & BUSCH, H. (1983). Indirect immunofluorescence studies of proliferating cell nuclear antigen in nucleoli of human tumour and normal tissues. Cancer Res., 43, 3770-3777.
7. CHARPIN, C, ANDROC, L., VACHERET, H., HABIB, M. C., DEVICTOR, B., LAVAUT, M. N. & TOGA’, M. (1988). Multiparametric evaluation (SAMBA) of growth fraction (Monoclonal Ki-67) in breast carcinoma tissue sections. Cancer Res., 48, 4368-4374.
8. COX, D. R. & HINKLEY, D. V. (1974). Theoretical Statistics. Chapman and Hall: London, 314-317.
9. DEXTER, D. L., KOWALSKY, H. M., BLAZER, B. A., FLIGIEL, Z., VOGEL, R. & HEPPNER, G. H. (1978). Heterogeneity of tumour cells from a single mouse mammary tumour. Cancer Res., 38, 3174-3181.
10. EORTC BREAST CANCER COOPERATIVE GROUP (1973). Standards for the assessment of estrogen receptor in human breast cancer. Eur. J. Cancer, 9, 379-381.
11. FISHER, B., RAVDIN, R. G., AUSMAN, R. K., SLACK, N. H., MOORE, G. E. & NOER, R. J. (1968). Surgical adjuvant chemotherapy in cancer of the breast: Results of a decade of cooperative investigation. Ann. Surg., 168, 337-342.
12. FISHER, E. R., GREGORIO, R. M. & FISHER, B. (1975). The pathology of invasive breast cancer: A syllabus derived from the findings of the National Surgical Adjuvant Breast Project (protocol n°4). Cancer, 36, 1-85.
13. FITZPATRICK, S. L., LA CHANCE, M. P. & SCHULTZ, G. S. (1984). Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res., 44, 3442-3447.
14. FOEKENS, J. A., PORTENGEN, H., VAN PUTTEN, W. L. J., TRAPMAN, A. M. A. C., REUBI, J. C., ALEXIEVA-FIGUSCH, J. & KLIJN, J. G. M. (1989). Prognostic value of receptors for Insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res., 49, 7002-7009.
15. 1 phase. Cancer Res., 48, 1244-1251.
16. GASPARINI, G., DAL FIOR, S., POZZA, F. & BEVILACQUA, P. (1989). Correlation of growth fraction by Ki-67 immunocytochemistry with histologic factors and hormone receptors in operable breast carcinoma. Breast Cancer Res. Treat., 14, 329-336.
17. GASPARINI, G., REITANO, M., BEVILACQUA, P., MELI, S., POZZA, F. & SANTINI, G. (1991). Relationship of the epidermal growth factor-receptor to the growth fraction (Ki-67 antibody) and the flow cytometric S-phase as cell kinetics parameters, in human mammary carcinomas. Anticancer Res., 11, 1597-1604.
18. GASPARINI, G., POZZA, F., BEVILACQUA, P., MELI, S., BORACCHI, P., REITANO, M., SANTINI, G., MARUBINI, E. & SAINSBURY, J. R. C. (1992a). Growth fraction (Ki-67 antibody) determination in stage I-II breast carcinoma: histologic, clinical and prognostic correlations. The Breast, 1, 92-99.
19. GASPARINI, G., GULLICK, W. L., BEVILACQUA, P., SAINSBURY, J. R. C., MELI, S., BORACCHI, P., TESTOLIN, A., LA MALFA, G. & POZZA, F. (1992b). Human breast cancer: Prognostic significance of the c-erbB-2 Oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features. J. Clin. Oncol., 10, 684-693.
20. GASPARINI, G., FOLKMAN, J., POZZA, F., BEVILACQUA, P., MELI, S. & WEIDNER, N. (1992c). Tumor angiogenesis (TA) quantitation by factor VIII-related antigen immunocytochemistry: A new, highly significant, and independent prognostic indicator in early-stage breast cancer carcinoma. Abstr. N°40 in Proceedings of the ASCO Meeting. San Diego 17-20 May.
21. GERDES, J., LEMKE, H., BAISCH, H., WACKER, H. H., SCHAWAB, U. & STEIN, H. (1984). Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol., 133, 1710-1717.
22. GORE, S. M., POCOCK, S. J. & KERR, G. R. (1984). Regression models and nonproportional hazards in the analysis of breast cancer survival. Appl. Statist., 33, 176-195.
23. HEDLEY, D. W., RUGG, C. A. & GELBER, R. D. (1987). Association of DNA index and S-phase fraction with prognosis of node positive early breast cancer. Cancer Res., 47, 4729-4735.
24. HELDIN, C. H. & WESTERMARK, B. (1984). Growth factors: mechanisms of action and relation to oncogenes. Cell, 37, 9-15.
25. HSU, S. M., RAINE, L. & FANGER, H. (1981). A comparative study of the peroxidase antiperoxidase method and an avidin-biotin-complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Path., 75, 734-738.
26. ISOLA, J. J., HELIN, H. J., HELLE, M. J. & KALLIONIEMI, O. P. (1990). Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count. Cancer, 65, 1180-1184.
27. KALAFONOS, H. P., PAWLIKOWSKA, T. R. & HEMINGWAY, A. (1989). Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase. J. Nucl. Med., 30, 1636-1645.
28. KAPLAN, E. L. & MEYER, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53, 457-481.
29. KOENDERS, P. G., BEEX, L. V. A. M., GEURTS-MOESPOT, A., HEUVEL, J. J. T. M., KIENHUIS, C. B. M. & BENRAAD, T. J. (1991). Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res., 51, 4544-4548.
30. LEWIS, S., LOCKER, A., TODD, J. H., BELL, J. A., NICHOLSON, R., ELSTON, C. W., BLAMEY, R. W. & ELLIS, I. O. (1990). Expression of epidermal growth factor receptor in breast carcinoma. J. Clin. Pathol, 43, 385-389.
31. LIPPMAN, M E., DICKSON, R. B., BATES, C, HUGG, K., SWAIN, S., MCMAMAWAY, BRONZERT, D., KASID, A. & GELMANN, E. P. (1986). Autocrine and paracrine growth regulation of human breast cancer. Breast CAncer Res. Treat., 7, 59-70.
32. MACIAS, A., AZAVEDO, E., HAGERSTROM, T., KLINTEMBERG, C, PEREZ, R. & SKOOG, L. (1987). Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. Anticancer Res., 7, 459-464.
33. MCGUIRE, W. L. (1987). Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res. Treat., 10, 5-9.
34. NEAL, D. E., MARSH, C, BENNETT, M. K., ABEL, P. D., HALL, R. R., SAINSBURY, J. R. C. & HARRIS, A. L. (1985). Epidermal growth factor receptors in human bladder cancer: comparisons of invasive and superficial tumours. Lancet, 1, 366-368.
35. NICHOLSON, S., SAINSBURY, J. R. C., HALCROW, P., KELLY, P., ANGUS, B., WRIGHT, C, HENRY, J., FARNDON, J. R. & HARRIS, A. L. (1991). Epidermal Growth Factor receptor (EGFr); Results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br. J. Cancer, 63, 146-151.
36. OFFICE OF MEDICAL APPLICATION OF RESEARCH. NATIONAL INSTITUTE OF HEALTH, BETHESDA, MD CONSENSUS CONFERENCE. (1985). Adjuvant chemotherapy for breast cancer. JAMA, 254, 3461-3463.
37. PEYRAT, J. P., BONNETIERE, J., VANDEWALLE, B., DJIARRE, J. & LEFEBURE, J. (1984). Recepteurs de I’EGF dans les cancers du sein humains. Relations avec les recepteurs hormonaux. Annales Endocr., 45, 412-413.
38. PEKONEN, F., PARTANEN, S., MAKINEN, T. & RUTANEN, A. M. (1988). Receptors for epidermal growth factor and insuline-like growth factor 1 and their relation to steroid receptors in human breast cancer. Cancer Res., 48, 1343-1347.
39. ROOS, W., FABBRO, D., KUNG, W., COSTA, S. D. & EPPENBERGER, U. (1986). Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumour promoters in human mammary carcinoma cells. Proc. Natl Acad. Sci. USA, 83, 991-995.
40. SALOMON, D. S., ZWIEBEL, J. A., BANO, M., IOSONCZY, L, FEHNEL, P. & KIDWELL, W. R. (1984). Presence of transforming growth factors in human breast cancer cells. Cancer Res., 44, 4069 -4077.
41. SAINSBURY, J. R. C., FARNDON, J. R., SHERBET, V. G. & HARRIS, A. L. (1985). Epidermal growth-factor receptors and oestrogen receptors in human breast cancer. Lancet, i, 364-366.
42. SAINSBURY, J. R., FARNDON, J. R., NEEDHAM, G. K., MALCOLM, A. J. & HARRIS, A. L. (1987). Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet, ii, 1398-1402.
43. SILVESTRINI, R., DAIDONE, M. G. & GASPARINI, G. (1985). Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer, 56, 1982-1987.
44. SPYRATOS, F., DELARUE, J. C., ANDRIEU, C, LIDEREAU, R., CHAMPEME, M. H., HACENE, K. & BRUNET, M. (1990). Epidermal growth factor receptors and prognosis in primary breast cancer. Breast Cancer Res. Treat., 17, 83-89.
45. STOSCHECK, C. M. & KING, L. E. (1986). Role of epidermal growth factor in carcinogenesis. Cancer Res., 46, 1030-1037.
46. TOI, M., AKIHKO, O., YAMADA, H. & TOGE, T. (1991). Epidermal Growth Factor Receptor expression as a prognostic indicator in breast cancer. Eur. J. Cancer, 27, 977-980.
47. TUBIANA, M., PEJOVIC, M. H., CHAVAUDRA, G., CONTESSO, G. & MALAISE, E. P. (1984). The long-term prognostic significance of the tymidine labeling index in breast cancer. Int. J. Cancer, 33, 441-445.
48. WALKER, R. A. & CAMPLEJOHN, R. S. (1986). DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J. Pathol., 150, 37-42.
49. WATERFIELD, M. D., MAYERS, E. L. V., STROOBANT, P., BENNET, P. L. P., YOUNG, S., GOODFELLOW, P. N., BANTING, G. S. & OZANNE, B. (1982). A monoclonal antibody to the human epidermal growth factor receptor. J. Cell Biochem., 20, 149-161.
50. WRIGHT, C, ANGUS, B., NICHOLSON, S., SAINSBURY, J. R. C., CAIRNS, J., GULLICK, W. J., KELLY, P., HARRIS, A. L. & HORNE, C. H. W. (1989). Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res., 49, 2087-2090.